Clinical Nutrition Market Size, Share, Trends, Report By 2032

The global clinical nutrition market size was valued at US$ 38 billion in 2023 and is projected to hit over US$ 70.33 billion by 2032, growing at a noteworthy CAGR of 6.40% from 2023 to 2032.

A clinical nutrition is a sort of medicine that aids in the overall health of a patient. It aids in the improvement of the metabolic system by supplying sufficient supplements such as vitamins, minerals, and other nutrients. Clinical nutrition helps to avoid diet related disorders by diagnosing and treating diseases that impact the intake, intestinal absorption, and metabolism of dietary elements. Cardiac rehabilitation, diabetes, renal dialysis, cancer, wellness centers, and community-basedintervention programs are among the areas where it is used.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1527

The rising prevalence of metabolic disorders, increasing healthcare spending, and the expansion of the middle class in emerging nations are all factors moving the clinical nutrition market forward. The metabolic disorders have become more common in recent years.

Report Highlights

Based on the route of administration, the oral segment dominated the global clinical nutrition market in 2020 with highest market share. As the enteral and parental segments are costly due to the cost of processing nutrients or goods, the oral segment has dominated the market. The oral category has the biggest market share, and this trend is projected to continue throughout the year. This increase can be linked to its widespread and consistent use among patients due to its ease of use and availability for a variety of ailments.
Based on the end user, the pediatric segment is estimated to be the most opportunistic segment during the forecast period. The concerns regarding malnutrition in children are projected to be a prominent growth factor in the clinical nutrition market.

Regional Snapshot

North America is the largest segment for clinical nutrition market in terms of region. Fast food consumption contributes to chronic health problems due to the high levels of trans fats, saturated fats, and sodium in this diet. The hypertension, diabetes, and cardiovascular diseases are all linked to these ingredients.

Asia-Pacific region is the fastest growing region in the clinical nutrition market. The Asia-Pacific has a high prevalence of metabolic syndrome, which is characterized by anomalies such as obesity, hypertension, and raised blood glucose levels. The number of multimorbid patients is likewise increasing as people get older.

Table of Contents

Scope of the Clinical Nutrition Market

Report Coverage	Details
Market Size	US$ 70.33 Billion by 2032
Growth Rate	CAGR of 6.40% from 2023 to 2032
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	Route of Administration, End User, Application, Region

Clinical Nutrition Market Dynamics

Drivers

Surge in demand for probiotics and functional food products

The significant increase in the number of health-conscious consumers, combined with the rising demand for functional food and beverages, is expected to have a significant impact on the overall growth of the global clinical nutrition products market over the next decade. Because of the sheer size of the market and the consistent rise in the number of health-conscious consumers, the Asia Pacific region is likely to be one of the most lucrative markets for players operating in the current clinical nutrition products market landscape. Furthermore, the growing geriatric and elderly populations in developing countries are expected to drive up demand for clinical nutrition in the near future.

Restraints

Lack of consumer awareness

The people are unaware about the nutrition products. They lack knowledge about the different types of clinical nutrition for different types of age group people. The clinical nutrition products are available for the infants as well. Hence, the lack of awareness among consumers is a restricting factor for the growth of the clinical nutrition market during the forecast period.

Opportunities

Rising prevalence of chronic disorders

The growing number of people worldwide suffering from chronic diseases such as diabetes and cancer, combined with the significant growth in the geriatric population, will fuel the clinical nutrition market’s growth in the coming years. Because those suffering from chronic disorders have a deficiency in essential nutrients, the rise in chronic disorders has necessitated the use of clinical nutrition prescriptions. Furthermore, the growing obese population base as a result of poor eating habits and a lack of exercise can propel clinical nutrition market growth. Elderly people frequently lose their appetites or have digestive problems, necessitating nutrient administration via enteral or parenteral routes. This factor is expected to benefit the global clinical nutrition market over the next few years. Furthermore, the significant increase in premature births, as well as the overall high birth rate around the world, may benefit the global market. Thus, the rising prevalence of chronic disorders is creating lucrative opportunities for the growth of the clinical nutrition market.

Challenges

Stringent government regulations

The stringent regulations and reimbursement issues are expected to stymie market growth. Clinical nutrition products are classified as pharmaceuticals.Thus, the major market players need to follow certain laws and guidelines set by Food and Drug Administration (FDA). As a result, the strict government regulatory frameworks are a major challenge for the growth of the clinical nutrition market during the forecast period.

Some of the prominent players in the global clinical nutrition market include:

Abbott Laboratories
B. Braun Melsungen AG.
Mead Johnson Nutrition Company
Perrigo Company Plc.
H.J. Heinz Company
Hospira Inc.
Groupe Danone
Fresenius Kabi AG
Baxter International Inc.
Nestle SA

Segments Covered in the Report

By Route of Administration

Oral
Enteral
Parental

By Application

Cancer
Metabolic Disorders
Gastrointestinal Disorders
Neurological Disorders
Others

By End User

Pediatric
Adult
Geriatric

By Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa